entertainment -WSS

entertainment

author：fashion 2025-10-02 23:48:29 - browse：98

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： New chart reveals military’s vast involvement in Operation Warp Speed

WSS

What to know about Virgin Galactic's 1st mission taking paying customers to space

American woman, child freed after being kidnapped in Haiti last month

How to use technology to prevent future drug shortages

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Police still searching for prisoner who escaped from NYC hospital

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

explore

entertainment

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

New chief aims to remake Sanofi Genzyme

Dobbs anniversary: the lost opportunity of abortion as health care

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

How one medical school became remarkably diverse

New chief aims to remake Sanofi Genzyme

Sports medicine is finally prioritizing gender equality

Trump Organization, Michael Cohen agree to settle million

How to save PrEP access — and even expand it

For Cytokinetics, FDA rejection of heart drug would help, not hinder

explore

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Prosecutors say FTX founder Sam Bankman

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Methadone doses haven’t kept up in the age of fentanyl

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Prosecutors say FTX founder Sam Bankman

entertainment

entertainment

explore

leisure time